66 related articles for article (PubMed ID: 29778513)
21. Recombinant vaccinia vector-based vaccine (Tiantan) boosting a novel HBV subunit vaccine induced more robust and lasting immunity in rhesus macaques.
Deng Y; Chuai X; Chen P; Chen H; Wang W; Ruan L; Li W; Tan W
Vaccine; 2017 Jun; 35(25):3347-3353. PubMed ID: 28487055
[TBL] [Abstract][Full Text] [Related]
22. Protective efficacy and hepatitis B virus clearance in mice enhanced by cell-mediated immunity with novel prime-boost regimens.
Chuai X; Chen P; Chen H; Wang W; Deng Y; Ruan L; Li W; Tan W
J Viral Hepat; 2017 Apr; 24(4):337-345. PubMed ID: 27885748
[TBL] [Abstract][Full Text] [Related]
23. Immune responses to recombinant Mycobacterium smegmatis expressing fused core protein and preS1 peptide of hepatitis B virus in mice.
Yue Q; Hu X; Yin W; Xu X; Wei S; Lei Y; Lü X; Yang J; Su M; Xu Z; Hao X
J Virol Methods; 2007 Apr; 141(1):41-8. PubMed ID: 17197041
[TBL] [Abstract][Full Text] [Related]
24. [Boosting with HBV subunit particle vaccine enhance immune response of novel DNA vaccine consisting of S-PreS1 fusion gene in mice].
Chen H; Deng Y; Tan W; Wang W; Guan J; Wen B; Yin X; Ruan L
Sheng Wu Gong Cheng Xue Bao; 2011 Jan; 27(1):95-100. PubMed ID: 21553495
[TBL] [Abstract][Full Text] [Related]
25. Recombinant hepatitis B core antigen carrying preS1 epitopes induce immune response against chronic HBV infection.
Chen X; Li M; Le X; Ma W; Zhou B
Vaccine; 2004 Jan; 22(3-4):439-46. PubMed ID: 14670326
[TBL] [Abstract][Full Text] [Related]
26. The immune response of rhesus macaques to novel vaccines comprising hepatitis B virus S, PreS1, and Core antigens.
Chuai X; Xie B; Chen H; Tan X; Wang W; Huang B; Deng Y; Li W; Tan W
Vaccine; 2018 Jun; 36(26):3740-3746. PubMed ID: 29778513
[TBL] [Abstract][Full Text] [Related]
27. DNA vaccines for prophylactic or therapeutic immunization against hepatitis B.
Michel ML; Loirat D
Intervirology; 2001; 44(2-3):78-87. PubMed ID: 11509869
[TBL] [Abstract][Full Text] [Related]
28. Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine.
Shouval D; Roggendorf H; Roggendorf M
Med Microbiol Immunol; 2015 Feb; 204(1):57-68. PubMed ID: 25557605
[TBL] [Abstract][Full Text] [Related]
29. Revealing the potential of DNA-based vaccination: lessons learned from the hepatitis B virus surface antigen.
Schirmbeck R; Reimann J
Biol Chem; 2001 Apr; 382(4):543-52. PubMed ID: 11405219
[TBL] [Abstract][Full Text] [Related]
30. Peptide vaccines against hepatitis B virus: from animal model to human studies.
Engler OB; Dai WJ; Sette A; Hunziker IP; Reichen J; Pichler WJ; Cerny A
Mol Immunol; 2001 Dec; 38(6):457-65. PubMed ID: 11741695
[TBL] [Abstract][Full Text] [Related]
31. The application of molecular biology to the development of novel vaccines.
Kniskern PJ; Hagopian A; Burke P; Dunn N; Montgomery DL; Schultz LD; Schulman CA; Carty CE; Maigetter RZ; Wampler DE
Adv Exp Med Biol; 1989; 251():83-98. PubMed ID: 2532858
[TBL] [Abstract][Full Text] [Related]
32. Molecular and genetic aspects of the immune responses to hepatitis B viral antigens.
Milich DR
Adv Exp Med Biol; 1989; 257():115-33. PubMed ID: 2482667
[TBL] [Abstract][Full Text] [Related]
33. Newer directions in vaccine development and utilization.
Hilleman MR
J Infect Dis; 1985 Mar; 151(3):407-19. PubMed ID: 2982958
[TBL] [Abstract][Full Text] [Related]
34. New approaches to hepatitis A and B vaccines.
Iwarson S
APMIS; 1995 May; 103(5):321-6. PubMed ID: 7654355
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity of hepatitis B vaccines: implications of immune memory.
Koff RS
Vaccine; 2002 Nov; 20(31-32):3695-701. PubMed ID: 12399197
[TBL] [Abstract][Full Text] [Related]
36. Genetic engineering applied to the development of vaccines.
Murray K; Stahl S; Ashton-Rickardt PG
Philos Trans R Soc Lond B Biol Sci; 1989 Aug; 324(1224):461-76. PubMed ID: 2573084
[TBL] [Abstract][Full Text] [Related]
37. Protective potential of hepatitis B virus antigens other than the S gene protein.
Gerlich WH; Deepen R; Heermann KH; Krone B; Lu XY; Seifer M; Thomssen R
Vaccine; 1990 Mar; 8 Suppl():S63-8; discussion S79-80. PubMed ID: 1691567
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
